Tag: shows 81% efficacy
Phase 3 Clinical Trial of COVAXIN, developed by ICMR & Bharat Biotech, shows 81%...
Phase 3 Clinical Trial of COVAXIN, developed by ICMR & Bharat Biotech, shows 81% efficacyThe results, evaluated by an independent data safety and monitoring board, show that the vaccine is well-tolerated and efficacious against...